Healthcare Resource Utilization and Costs for Empagliflozin Versus Glucagon-Like Peptide-1 Receptor Agonists in Routine Clinical Care in Denmark.
Reimar Wernich ThomsenLotte W B ChristensenJohnny KahlertJakob S KnudsenAnastasia UstyugovaSusanne SandgaardPia HolmgaardLars H EhlersHenrik T SørensenPublished in: Diabetes therapy : research, treatment and education of diabetes and related disorders (2022)
The study protocol and analysis plan have been registered on the website of the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCEPP) ( http://www.encepp.eu/encepp/viewResource.htm?id=37726 , first protocol registration 4 June 2019), and on clinicaltrials.gov ( https://clinicaltrials.gov/ct2/show/NCT03993132 , first posted 20 June 2019).
Keyphrases
- healthcare
- randomized controlled trial
- study protocol
- palliative care
- computed tomography
- clinical trial
- quality improvement
- clinical practice
- positron emission tomography
- dual energy
- emergency department
- contrast enhanced
- open label
- magnetic resonance
- health insurance
- placebo controlled
- data analysis
- network analysis